Mind Uploading (Whole Brain Emulation)

The Process

The uploading idea assumes the mind is an informational system. This concept rests on the process of scanning and mapping a biological brain in extreme detail, then transferring its structure, neuronal connections, and electrochemical states into a computer system or robotic substrate — effectively "migrating" a mind to a non-biological medium.
In most models, this would be achieved through a surgical procedure involving microscopic nanobots that map, replace, and emulate individual brain cells with digital components, gradually substituting biological tissue with functionally equivalent hardware.

Current State of Research

Despite decades of speculation, mind uploading remains entirely theoretical: no human mind, nor any complex animal mind, has ever been transferred to a digital substrate. Nevertheless, efforts in multiple areas of ongoing research, including neuroscience, nanotechnology, and artificial intelligence, are gradually being deployed to build the foundations the concept depends on.

The EU’s Human Brain Project and Switzerland’s Blue Brain Project pioneered large‑scale brain modelling and neural simulation, laying important groundwork for the idea of whole brain emulation. The Human Brain Project produced mixed results: its initial ambition to simulate the entire human brain was widely criticised by neuroscientists as unrealistic, and in 2014 nearly 800 researchers, including Nobel laureates, signed an open letter denouncing its governance and scientific direction. A mediation committee largely validated these criticisms, leading to a major restructuring in 2015 that redirected the project toward building shared digital infrastructure, such as the Human Brain Atlas, rather than attempting a full brain simulation. Blue Brain, its Swiss predecessor, adopted a narrower and more sustainable strategy: instead of targeting the human brain, it focused on constructing and validating a detailed digital reconstruction of the mouse brain, a more modest but scientifically grounded milestone.

In October 2024, the FlyWire Consortium published the first complete connectome of an adult fruit fly brain, mapping over 50 million connections between more than 130,000 neurons — the most complex brain ever fully wired-mapped. Brain-computer interfaces such as BrainGate have separately made progress on the input/output side, enabling thought-based cursor control and communication in clinical trials since the early 2000s. New imaging methods, including ultra-high gradient MRI for connectomics published in 2025, aim to close the resolution gap needed for whole-brain mapping in larger organisms.

Another emerging field progressing in parallel is brain-computer interfaces (BCI), notably driven by Neuralink, the company founded by Elon Musk and a team of engineers. After an initial rejection over safety concerns, the FDA approved Neuralink's first human clinical trial in 2023, and the company implanted its first human patient in January 2024, a paralyzed man able to control a computer cursor by thought. Since then, Neuralink has significantly expanded its human trials. As of early 2026, over 20 participants worldwide were enrolled, with the company reporting no serious device related adverse events. Neuralink is also developing a second device, Blindsight, aimed at restoring vision by directly stimulating the brain's visual cortex. Blindsight received FDA Breakthrough Device Designation in September 2024, a status that accelerates regulatory review but does not constitute approval. The device has so far only been tested in non human primates, and the first human implant is expected sometime in 2026.
According to the FDA's website, on July 21, 2026, a meeting took place between FDA officials and Neuralink executives, including company president Dongjin Seo, to discuss regulatory pathways for accelerating medical device innovation.

As of August 2026, a search on ClinicalTrials.gov lists seven clinical trials involving Neuralink, four of them are geographic variants of the same core study (PRIME), replicated in the United States, the United Kingdom, Canada, and the United Arab Emirates to broaden patient recruitment and satisfy different national regulators. The remaining trials include VOICE, focused on speech restoration, and two smaller studies evaluating assistive-device control and long-term clinical outcomes. Nearly all are actively recruiting, spanning academic medical centers across four countries, with each targeting patients affected by conditions such as ALS, spinal cord injury, or quadriplegia.
These clinical trials remain fundamentally different from mind uploading. Neuralink's implants read and write narrow slices of neural activity, enough to move a cursor, form words, or restore basic vision, but they capture nothing resembling the full structure of a mind. Closing that gap remains the central unsolved challenge between today's brain-computer interfaces and any future vision of digital immortality.

Neuralink is not the only player in the field of brain-computer interfaces, Shanghai-based StairMed Technology is developing a less invasive, endovascular implantation method, inserting a chip through blood vessels in the neck and guiding it to the brain via the vascular system, similar to how a stent is placed.

Paradromics, widely seen as one of Neuralink's closest rivals, received FDA approval for a long-term clinical trial and will implant its device in two volunteers in early 2026, aiming to restore real-time speech for people with severe motor impairments.

On the brain emulation side, the academic FlyWire Consortium completed the first full connectome of a fruit fly brain in 2024, mapping every neuron and synaptic connection. Building on that achievement, the company Eon Systems brought the map to life: in 2026, it ran the first simulated fruit fly brain controlling a virtual body, with a mouse‑brain emulation set as its next milestone. Taken together, these efforts illustrate the two main technological pathways toward mind uploading: interfacing with the brain and emulating it.

Advanced imaging is also making strides on another front: non-invasive scanning of the living human brain. In 2025, researchers at Massachusetts General Hospital and Harvard Medical School introduced Connectome 2.0, an ultra-high-gradient MRI scanner capable of resolving microscopic brain structures in living humans without surgery. While its resolution has yet to achieve synaptic-level precision, it represents a groundbreaking, non-invasive approach to brain connectomics, eliminating the need for implants or tissue destruction.

The gap between these advances and mind uploading itself remains vast. As of early 2026, scientists cannot yet replace a single real neuron with an artificial one, and no human mind has been successfully uploaded or emulated. Estimates for when — or whether — whole brain emulation might become achievable vary widely, from a few decades to as long as 100 to 200 years, with most researchers cautioning against near-term expectations of virtual immortality.

Mind Uploading and Virtual Immortality

Mind uploading is a cornerstone of virtual immortality, and together, the two concepts form key pillars of transhumanist thought. Virtual immortality depends entirely on whether mind uploading proves feasible. Without the ability to accurately capture and replicate the intricate workings of the human brain, the dream of escaping death by migrating to a digital or synthetic existence remains, for now, purely theoretical.

The Copy Problem

The most profound philosophical dilemma of mind uploading and virtual immortality is the copy problem: even with a perfect, neuron-by-neuron digital reconstruction, it remains unresolved whether this process achieves continuity of consciousness or merely creates a high-fidelity duplicate. If your mind is uploaded into a machine, does your subjective experience persist—or is the resulting entity merely a replica, while the original biological "you" ceases to exist? Without resolving this, the promise of virtual immortality remains fundamentally unproven.